South Africa restarting J&J Covid-19 vaccine jabs according

South Africa restarting J&J Covid-19 vaccine jabs according to conditions
Issued on:
18/04/2021 - 19:57
A South African healthcare worker receives a jab of the J&J Covid-19 vaccine at the Klerksdorp Hospital on 18 February 2021. © AFP - Phill Magakoe
4 min
Authorities in South Africa should lift a suspension of use of the Johnson & Johnson Covid-19 vaccine if a number of conditions are met, the country’s health regulator has announced.
Advertising
Read more
South African Health Products Regulatory Authority (SAHPRA) said it had “recommended that the pause in the Sisonke study be lifted, provided that specific conditions are met”, referring to the clinical trial that allows Pretoria to make the single dose J&J vaccine available to healthcare workers.

Related Keywords

South Africa , Denmark , Pretoria , Gauteng , South African , Aspen Pharmacare , Cyril Ramaphosa , Astrazeneca , African Vaccine Acquisition Task Team , African Health Products Regulatory Authority , Associated Press , Oxford University , African Medical Research Council , South African Medical Research Council , South African President Cyril Ramaphosa , Cerebral Venous Thrombosis , Saharan Africa , Africa Centres , Disease Control , Africa , Medicine , Corona Virus , Vaccine , டென்மார்க் , ப்ரிடாரீய , கௌஊட்டெங் , ஆஸ்பென் மருந்தகம் , தொடர்புடையது ப்ரெஸ் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , சிஇஆர்இபிஆர்ஏஎல் சிரை த்ரோம்போசிஸ் , நோய் கட்டுப்பாடு , மருந்து , கொரோனா வைரஸ் , தடுப்பூசி ,